Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00315406 · ClinicalTrials.gov registry record
Determining Disease Activity Biomarkers in Individuals With Polyarteritis Nodosa
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 107
- Enrollment target
NCT00315406: Completed study, sponsored by University of Pennsylvania.
NCT00315406 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 107 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00315406 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 107 participants
- Enrollment target
Study Summary
Polyarteritis nodosa (PAN) is a rare immune system disorder that causes swelling and damage to small- and medium-sized blood vessels in the body. In order to properly treat this disease, it is critical that the level of disease activity can be determined over the course of the disease. The purpose of this study is to determine new biological markers, or biomarkers, that may be used to assess the severity of disease in people with PAN.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2006-04 |
| Est. Completion | 2019-12 |
What the finished NCT00315406 record still lists
NCT00315406 is an observational study that tracks outcomes without assigning an intervention. The registered 107 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00315406 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00315406 about?
NCT00315406 is a clinical study titled "Determining Disease Activity Biomarkers in Individuals With Polyarteritis Nodosa". Polyarteritis nodosa (PAN) is a rare immune system disorder that causes swelling and damage to small- and medium-sized blood vessels in the body. In order to properly treat this disease, it is critical that the level of disease activity can be determined over the course of the disease. The purpose o...
What is the current status of trial NCT00315406?
This trial is currently completed. The enrollment target is 107 participants. The study started on 2006-04. Estimated completion is 2019-12.
Who is sponsoring clinical trial NCT00315406?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05491668 · 107 participants
Physiological Assessment of Severe Coronary Stenosis for Informing Planned PCI
- NCT06041594 · 107 participants · NA
Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)
- NCT06081426 · 107 participants · NA
Examining Neurobiological Mechanisms Underlying the Therapeutic Effect of the Ketogenic Diet in Bipolar Disorder (BD)
- NCT06527599 · 107 participants · NA
Screening in Trauma for Opioid Misuse Prevention - an Adaptive Intervention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia